Eduardo Jucá1,2,3, André Pessoa4,5, Erlane Ribeiro4,6, Rafaela Menezes6, Saile Kerbage4, Thayse Lopes6, Luciano Pamplona Cavalcanti7. 1. Universidade de Fortaleza (UNIFOR), Fortaleza, Ceará, Brazil. eduardojuca@gmail.com. 2. Hospital Infantil Albert Sabin, Fortaleza, Ceará, Brazil. eduardojuca@gmail.com. 3. Centro Universitário Christus, Fortaleza, Ceará, Brazil. eduardojuca@gmail.com. 4. Hospital Infantil Albert Sabin, Fortaleza, Ceará, Brazil. 5. Universidade Estadual do Ceará-UECE, Fortaleza, Brazil. 6. Centro Universitário Christus, Fortaleza, Ceará, Brazil. 7. Universidade Federal do Ceará, Fortaleza, Ceará, Brazil.
Abstract
PURPOSE: Congenital Zika syndrome (CZS) is a new entity with little information about its course and natural history. It is known that prenatal infection by Zika virus is associated to disrupted nervous system development, leading to typical neurological disabilities and deformities. Some children present progressive ventriculomegaly and hydrocephalus associated to aggravation of seizures and neurological impairment. The aim of this study is to evaluate the development of hydrocephalus and the impact of ventriculoperitoneal shunt insertion in the clinical condition of these children. METHODS: Data was obtained from chart review, direct interviews with patients' parents, direct neurological examination, and analysis of pre- and postoperative neuroimages. RESULTS: A group of 115 patients had CZS diagnosis from November 2015 to July 2017. Among them, 21 (18.3%) patients had ventricular enlargement noted on follow-up CT scans. Six children (28.6%) underwent a ventriculoperitoneal shunt and all had some improvement after surgery concerning either waking time during the day and better interaction. Overall improvement was also noted in seizures. Spasticity decrease and more cervical control were also achieved. In two out of six cases, a slight increase in parenchymal length could be noted on the CT scans. CONCLUSION: This series points out the possibility of hypertensive hydrocephalus development in CZS patients. Affected children may benefit from VP shunt insertion. These findings suggest a dual pathology association: fetal brain disruption and primary cortical malformation by the virus itself and hypertensive hydrocephalus. This is already seen in some cases of congenital rubella, toxoplasmosis, or cytomegalovirus-associated hydrocephalus.
PURPOSE: Congenital Zika syndrome (CZS) is a new entity with little information about its course and natural history. It is known that prenatal infection by Zika virus is associated to disrupted nervous system development, leading to typical neurological disabilities and deformities. Some children present progressive ventriculomegaly and hydrocephalus associated to aggravation of seizures and neurological impairment. The aim of this study is to evaluate the development of hydrocephalus and the impact of ventriculoperitoneal shunt insertion in the clinical condition of these children. METHODS: Data was obtained from chart review, direct interviews with patients' parents, direct neurological examination, and analysis of pre- and postoperative neuroimages. RESULTS: A group of 115 patients had CZS diagnosis from November 2015 to July 2017. Among them, 21 (18.3%) patients had ventricular enlargement noted on follow-up CT scans. Six children (28.6%) underwent a ventriculoperitoneal shunt and all had some improvement after surgery concerning either waking time during the day and better interaction. Overall improvement was also noted in seizures. Spasticity decrease and more cervical control were also achieved. In two out of six cases, a slight increase in parenchymal length could be noted on the CT scans. CONCLUSION: This series points out the possibility of hypertensive hydrocephalus development in CZS patients. Affected children may benefit from VP shunt insertion. These findings suggest a dual pathology association: fetal brain disruption and primary cortical malformation by the virus itself and hypertensive hydrocephalus. This is already seen in some cases of congenital rubella, toxoplasmosis, or cytomegalovirus-associated hydrocephalus.
Authors: Cynthia A Moore; J Erin Staples; William B Dobyns; André Pessoa; Camila V Ventura; Eduardo Borges da Fonseca; Erlane Marques Ribeiro; Liana O Ventura; Norberto Nogueira Neto; J Fernando Arena; Sonja A Rasmussen Journal: JAMA Pediatr Date: 2017-03-01 Impact factor: 16.193
Authors: David Olagnier; Michela Muscolini; Carolyn B Coyne; Michael S Diamond; John Hiscott Journal: DNA Cell Biol Date: 2016-06-27 Impact factor: 3.311
Authors: Lavinia Schuler-Faccini; Erlane M Ribeiro; Ian M L Feitosa; Dafne D G Horovitz; Denise P Cavalcanti; André Pessoa; Maria Juliana R Doriqui; Joao Ivanildo Neri; Joao Monteiro de Pina Neto; Hector Y C Wanderley; Mirlene Cernach; Antonette S El-Husny; Marcos V S Pone; Cassio L C Serao; Maria Teresa V Sanseverino Journal: MMWR Morb Mortal Wkly Rep Date: 2016-01-29 Impact factor: 17.586
Authors: Yasmin Notarbartolo di Villarosa do Amaral; Jocieli Malacarne; Paloma Glauca Brandão; Patrícia Brasil; Karin Nielsen-Saines; Maria Elisabeth Lopes Moreira Journal: Front Psychiatry Date: 2021-08-30 Impact factor: 5.435
Authors: Leão Vhp; M M Aragão; R S Pinho; A N Hazin; A R Paciorkowski; A C Penalva de Oliveira; Marcelo Rodrigues Masruha Journal: Curr Neurol Neurosci Rep Date: 2020-09-03 Impact factor: 5.081